•jan 2006 - present: international Vice President & General Manager eu Member of senior management of superdimension; a platform technology for intrabody navigation within the lungs and for the diagnosis and Treatment of peripheral lung diseases. •sep 2003 – jan 2006: ww Vice President Strategic Planning & General Manager eu, Member of senior management board of impulse dynamics and metacure. id therapy involves Treatment of heart failure patients. mc develops implantable Medical Devices for the Treatment of type ii Diabetes and obesity. •sep 2002 – sep 2003: CEO@ vasopharm biotech a Venture Capital funded German Pharmaceutical start-up company active in development of Diagnostics and therapeutics for cardiovascular and neurovascular indications.(sep 2003: completion of 1 year non-competition clause of j&j). •oct 1997 – sep 2002: Executive Director Market development @ biosense webster – j&j, a company specializing in Electrophysiology and wireless intrabody navigation. •feb. 1996 – oct 1997. General Manager for biosense europe an international R&D company with Leadership in intrabody navigational technologies. (oct 1997: acquisition of biosense by j&j for 483 m$). •dec 1994 - jan 1996: director sales&Marketing new business, cordis corporation (europe), international Biomedical company with emphasis in Cardiology, Electrophysiology and Neurology. (jan 1996: acquisition of cordis corp. by j&j; 1.8 b $). •dec. 1992 - nov. 1994: gm / s&m manager europe for uroplasty, an international urology company focused on microimplants for the Treatment of stress incontinence and vesicoureteral reflux. •oct 1989 - nov 1992: Sales Manager benelux of bioplasty, a subsidiary of an international Leader of implants and devices for plastic & reconstructive Surgery, maxillo-facial Surgery and Dermatology. (q3 1992 FDA ruling on breast implants: chapter 14 for bioplasty restructured as uroplasty)
Vice President & General Manager superDimension (acquisition May 2012)
Since May 2012
superdimension acquired by covidien in may 2012. superdimension is part of covidien's emerging technologies as interventional lung solutions. superDimension acquired by Covidien in May 2012. superDimension is part of Covidien's Emerging Technologies as Interventional Lung Solutions.
International Vice President/General Mgr Europe
Since January 2006
international Vice President & General Manager europe, Member of senior management of superdimension. superdimension has a platform technology for intrabody navigation within the pulmonary tree for the diagnosis and Treatment of peripheral lung diseases. responsibilities: + managing and directing of all activities of superdimension in europe. + managing the activities of superdimension personnel and Sales and Marketing activities direct in germany, france, uk, the netherlands and austria in addition to 14 distributors in emea. + develop and execute plans for Sales, Marketing and Public Relations activities associated with superdimension. + maintain Pricing and Reimbursement policies in 15 emea countries. + solidify relations with key pneumologists in the area of Diagnostic, staging and interventional pneumology as it relates to electro-magnetic pulmonary navigation. + supervise and manage the implementation of Clinical Education and Clinical support for all new and existing sites in emea. + manage Logistics and technical servicing for superdimension in emea, oversee ongoing projects with other departments, and carry out administrative duties and management of staff duties. International Vice President & General Manager Europe, member of senior management of superDimension. superDimension has a platform technology for intrabody navigation within the pulmonary tree for the diagnosis and treatment of peripheral lung diseases. RESPONSIBILITIES: + Managing and directing of all activities of superDimension in Europe. + Managing the activities of superDimension personnel and sales and marketing activities direct in Germany, France, UK, The Netherlands and Austria in addition to 14 distributors in EMEA. + Develop and execute plans for sales, marketing and public relations activities associated with superDimension. + Maintain pricing and reimbursement policies in 15 EMEA countries. + Solidify relations with key pneumologists in the area of diagnostic, staging and interventional pneumology as it relates to electro-magnetic pulmonary navigation. + Supervise and manage the implementation of clinical education and clinical support for all new and existing sites in EMEA. + Manage logistics and technical servicing for superDimension in EMEA, oversee ongoing projects with other departments, and carry out administrative duties and management of staff duties.
Chairman of the Board
Since January 2005
macropus cvba is a non-profit organization that manages real estate for organizations that help integrate people with a physical handicap in their home environment in the provice of east flanders in belgium. macropus cvba is funded by 65 shareholders and the gouvernemental agency de kangoeroe who supports over 500 families with a handicaped person in east flanders. Macropus cvba is a non-profit organization that manages real estate for organizations that help integrate people with a physical handicap in their home environment in the provice of East Flanders in Belgium. Macropus cvba is funded by 65 shareholders and the gouvernemental agency de Kangoeroe who supports over 500 families with a handicaped person in East Flanders.
WW Vice President and General Manager EMEASeptember 2003 --- January 2006
ww Vice President of Strategic Planning & General Manager europe, Member of senior management board of impulse dynamics and metacure. impulse dynamics has a platform technology of implantable devices for the modulation of non-excitatory cells. for Cardiology (impulse dynamics) the therapy involves Treatment of heart failure patients. metacure is developing implantable Medical Devices for the Treatment of type ii Diabetes and obesity. responsibilities: + managing and directing of all activities of impulse dynamics and metacure in europe. + managing Clinical protocols and european field Clinical engineers. hiring and Training personnel. + identification of Clinical investigational sites and development of relations with key cardiologists in the area of heart failure; endocrinologists, pancreatic Surgeons and diabetologists in the areas of obesity and Diabetes. + working with Hospital Ethics committees to get the impulse dynamics and metacure investigational units approved for Clinical studies, promoting the ccm (cardiac contractility modulation), gcm (gastric contractility modulation) and pst (pancreatic stimulation therapy) technology in europe. + managing the scientific work in the Research of ccm, gcm and pst and guiding physicians to conduct the Research and prepare peer review articles. + ww Strategic Planning.
Executive DirectorJanuary 1997 --- January 2002
Director Cordis WebsterJanuary 1994 --- January 1996
LinkedIn Assessment :
PhD in Biology from The University of Bonn in 1989
Area / Region
Deurle, Sint-Martens-Latem, Belgium